The Evolving Landscape of NMOSD and MOGAD: Clinical Insights, Diagnostic Challenges, and Treatment Innovations

The Evolving Landscape of NMOSD and MOGAD: Clinical Insights, Diagnostic Challenges, and Treatment Innovations Neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) represent a fascinating and evolving spectrum of central nervous system (CNS) inflammatory disorders. Historically, these conditions were often misdiagnosed as multiple sclerosis (MS), but advances in our understanding of […]